Clinical Trial

New Treatment of Common Wart

Name: New Treatment of Common Wart — clinical trial record (NCT07543926)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

this study aims to compare the efficacy and safety of platelet rich fibrin injection versus intralesional vitamin D injection in the treatmentof common warts. PRF, as an autologous biological material , may enhance tissue regeneration and immune response.

Trial Details

NCT Number	NCT07543926
Lead Sponsor	Sohag University
Conditions	Common Warts (Verruca Vulgaris)
Enrollment	70 participants
Start Date	2026-04-06
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-22